Jun Chang

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 13

Top Topics

Endoplasmic Reticulum Stress

Respiratory Syncytial Virus

Dendritic Cells

Immune Response

Top Venues

Clinical and experimental vaccine research

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Hyun-Jung Kong, Youngwon Choi, Eun-Ah Kim, Jun Chang
Vaccine Strategy That Enhances the Protective Efficacy of Systemic Immunization by Establishing Lung-Resident Memory CD8 T Cells Against Influenza Infection. Immune network 23 (4) (2023)
Jeong Pil Han, MinJeong Kim, Beom Seok Choi, Jeong Hyeon Lee, Geon Seong Lee, Michaela Jeong, Yeji Lee, Eun-Ah Kim, Hye-Kyung Oh, Nanyeong Go, Hyerim Lee, Kyu Jun Lee, Un Gi Kim, Jae Young Lee, Seokjoong Kim, Jun Chang, Hyukjin Lee, Dong Woo Song, Su Cheong Yeom
In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy. Science advances 8 (3) (2022)
Jun Chang
MHC multimer: A Molecular Toolbox for Immunologists. Molecules and cells 44 (5) (2021)
Jun Chang
Adenovirus Vectors: Excellent Tools for Vaccine Development. Immune network 21 (1) (2021)
Haerynn Chung, Eun-Ah Kim, Jun Chang
A "Prime and Deploy" Strategy for Universal Influenza Vaccine Targeting Nucleoprotein Induces Lung-Resident Memory CD8 T cells. Immune network 21 (4) (2021)
Myung Hee Kim, Hyun Jik Kim, Jun Chang
Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus. PloS one 14 (7) (2019)
So-Young Lee, Jung-Ok Kang, Jun Chang
Nucleoprotein vaccine induces cross-protective cytotoxic T lymphocytes against both lineages of influenza B virus. Clinical and experimental vaccine research 8 (1) (2019)
Yeong-Min Jo, Jungwoo Kim, Jun Chang
Vaccine containing G protein fragment and recombinant baculovirus expressing M2 protein induces protective immunity to respiratory syncytial virus. Clinical and experimental vaccine research 8 (1) (2019)
Ji-Min Ju, Min Ho Jung, Giri Nam, Woojin Kim, Sehwa Oh, Hyun Duk Kim, Joo Young Kim, Jun Chang, Sung Hak Lee, Gyeong Sin Park, Chang-Ki Min, Dong-Sup Lee, Moon Gyo Kim, Kyungho Choi, Eun Young Choi
Escape from thymic deletion and anti-leukemic effects of T cells specific for hematopoietic cell-restricted antigen. Nature communications 9 (1) (2018)
Hyo-Jeong Lee, Jeong-Yoon Lee, Min-Hee Park, Joo-Young Kim, Jun Chang
Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases. PloS one 12 (1) (2017)
Jung-Ok Kang, Jun Chang
Challenges in the development of T-cell-based universal influenza vaccines. Clinical and experimental vaccine research 6 (1) (2017)
Jeong-Yoon Lee, Jun Chang
Universal vaccine against respiratory syncytial virus A and B subtypes. PloS one 12 (4) (2017)
Jung-Ok Kang, Jee-Boong Lee, Jun Chang
Cholera Toxin Promotes Th17 Cell Differentiation by Modulating Expression of Polarizing Cytokines and the Antigen-Presenting Potential of Dendritic Cells. PloS one 11 (6) (2016)